scholarly journals Filling a Significant Gap in the Cardiac Intensive Care Unit (CICU): Quality Improvement Using the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) Approach

2020 ◽  
Vol 13 (1) ◽  
pp. 6-7
Author(s):  
S Butler ◽  
L Hartwell ◽  
J Thornton ◽  
M LaRonde ◽  
C Rachwal
2012 ◽  
Vol 12 ◽  
pp. S28-S32 ◽  
Author(s):  
Deborah Torowicz ◽  
Amy Jo Lisanti ◽  
Jeong-Sook Rim ◽  
Barbara Medoff-Cooper

2014 ◽  
Vol 25 (5) ◽  
pp. 951-957 ◽  
Author(s):  
Michael Gaies ◽  
David S. Cooper ◽  
Sarah Tabbutt ◽  
Steven M. Schwartz ◽  
Nancy Ghanayem ◽  
...  

AbstractDespite many advances in recent years for patients with critical paediatric and congenital cardiac disease, significant variation in outcomes remains across hospitals. Collaborative quality improvement has enhanced the quality and value of health care across specialties, partly by determining the reasons for variation and targeting strategies to reduce it. Developing an infrastructure for collaborative quality improvement in paediatric cardiac critical care holds promise for developing benchmarks of quality, to reduce preventable mortality and morbidity, optimise the long-term health of patients with critical congenital cardiovascular disease, and reduce unnecessary resource utilisation in the cardiac intensive care unit environment. The Pediatric Cardiac Critical Care Consortium (PC4) has been modelled after successful collaborative quality improvement initiatives, and is positioned to provide the data platform necessary to realise these objectives. We describe the development of PC4 including the philosophical, organisational, and infrastructural components that will facilitate collaborative quality improvement in paediatric cardiac critical care.


2020 ◽  
Vol 220 ◽  
pp. 93-100 ◽  
Author(s):  
Thomas A. Miller ◽  
Amy J. Lisanti ◽  
Madolin K. Witte ◽  
Justin J. Elhoff ◽  
William T. Mahle ◽  
...  

2020 ◽  
Vol 35 (2) ◽  
pp. 100-104
Author(s):  
Maksudur Rahman ◽  
Mohammad Abdullah Al Mamun ◽  
MAK Azad Chowdhury ◽  
Abu Sayeed Munsi

Background: Recently it has been apprehended that sildenafil, a drug which has been successfully using in the treatment of PPHN and erectile dysfunction in adult, is going to be withdrawn from the market of Bangladesh due to threat of its misuses. Objective: The aim of this study was to see the extent of uses of sildenafil in the treatment of PPHN and importance of availability of this drugs in the market inspite of its probable misuses. Methods: This cross sectional study was conducted in neonatal intensive care unit (NICU), special baby care unit (SCABU) and cardiac intensive care unit (CICU) of Dhaka Shishu (Children) Hospital from June, 2017 to May 2018. Neonates with PPHN were enrolled in the study. All cases were treated with oral sildenefil for PPHN along with others management according to hospital protocol. Data along with other parameters were collected and analyzed. Results: Total 320 patients with suspected PPHN were admitted during the study period. Among them 92 (29%) cases had PPHN. Male were 49(53 %) cases and female were 43(47%) cases. Mean age at hospital admission was 29.7±13.4 hours. Based on echocardiography,13(14%) cases had mild, 38 (41%) cases moderate and 41(45%) cases severe PPHN. Mean duration of sildenafil therapy was 11.9±7.1 days. Improved from PPHN were 83 (90%) cases. Mortality was 10% (9). Conclusion: In this study it was found that the incidence of PPHN is 29% among the suspected newborns. Sildenafil is successfull in improving the oxygenation of PPHN and to decrease the mortality of neonates. DS (Child) H J 2019; 35(2) : 100-104


Author(s):  
Pamela D. Reiter ◽  
Garth Wright ◽  
Ryan Good ◽  
Marisa Payan ◽  
Ann Lieb ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document